Skip to NavigationSkip to content

News

President Trump continues to push the drug hydroxychloroquine as a potential coronavirus treatment despite a lack of evidence for its effectiveness.
The European Commission has moved to authorise Ruxience, Pfizer’s biosimilar version of MabThera (rituximab).  The decision marks the seventh...
COVID-19 coronavirus treatments dominate the news as the world looks for a vaccine. Johnson & Johnson announced that it has selected a candidate...
New Phase 3 data for the blockbuster immunotherapy Keytruda showed that the anti-PD-1 therapy met one of its main goals in the first-line treatment...
A British man has been accused of smuggling a fake coronavirus cure into the US and has been federally charged.
Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results in children aged...
The European Medicines Agency has restricted the general use of the drug chloroquine for coronavirus, only allowing its testing in clinical trials.
The FDA is requesting that manufactures remove Zantac (ranitidine) from the market due to risks of it containing a carcinogen.
The product, developed by Laboratoire Francais du Fractionnement et des Biotechnologies, is indicated in the treatment and control of bleeding...
The FDA has concluded its investigation into Novartis and its data manipulation of the gene therapy Zolgensma, and has decided to place no penalties...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches